Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to 8.95.

  • Ironwood Pharmaceuticals' Interest Coverage Ratio rose 22883.33% to 8.95 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.65, marking a year-over-year increase of 1962.87%. This contributed to the annual value of 2.82 for FY2024, which is 10644.92% up from last year.
  • Ironwood Pharmaceuticals' Interest Coverage Ratio amounted to 8.95 in Q3 2025, which was up 22883.33% from 5.42 recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Interest Coverage Ratio ranged from a high of 44.93 in Q3 2022 and a low of 588.66 during Q2 2023
  • Moreover, its 5-year median value for Interest Coverage Ratio was 5.95 (2021), whereas its average is 18.39.
  • In the last 5 years, Ironwood Pharmaceuticals' Interest Coverage Ratio skyrocketed by 52940.95% in 2022 and then crashed by 243434.22% in 2023.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Interest Coverage Ratio stood at 7.12 in 2021, then surged by 529.41% to 44.8 in 2022, then crashed by 90.04% to 4.46 in 2023, then decreased by 20.84% to 3.53 in 2024, then skyrocketed by 153.34% to 8.95 in 2025.
  • Its Interest Coverage Ratio stands at 8.95 for Q3 2025, versus 5.42 for Q2 2025 and 3.61 for Q1 2025.